<?xml version="1.0" encoding="UTF-8"?>
<html xmlns:fo="http://www.w3.org/1999/XSL/Format"
	xmlns:xi="http://www.w3.org/2001/XInclude">
<head>
<meta xmlns="http://www.w3.org/1999/xhtml" http-equiv="Content-Type"
	content="text/html; charset=utf-8" />
<style type="text/css">
@media screen {
	.test-story-main legend {
		text-align: center;
		font-size: 110%;
		font-weight: bold;
	}
	.test-story-main .nav-tabs {
		font-weight: bold;
	}
	.test-story-main .tds_obxGrpSpl {
		background: #B8B8B8;
	}
	.test-story-main maskByMediaType {
		display: table;
	}
	.test-story-main table tbody tr th {
		font-size: 95%
	}
	.test-story-main table tbody tr td {
		font-size: 110%;
	}
	.test-story-main table tbody tr th {
		text-align: left;
		background: #C6DEFF;
		font-size: 100%;
	}
	.test-story-main fieldset {
		text-align: center;
	}
	.test-story-main table {
		width: 98%;
		border: 1px groove;
		table-layout: fixed;
		margin: 0 auto;
		border-collapse: collapse;
	}
	.test-story-main table tr {
		border: 2px groove;
	}
	.test-story-main table th {
		border: 2px groove;
	}
	.test-story-main table td {
		border: 1px groove;
	}
	.test-story-main table thead {
		border: 1px groove;
		background: #446BEC;
		text-align: center;
	}
	.test-story-main .separator {
		background: rgb(240, 240, 255);
		text-align: left;
	}
	.test-story-main table tbody tr td {
		text-align: left
	}
	.test-story-main .noData {
		background: #B8B8B8;
	}
	.test-story-main .childField {
		background: #B8B8B8;
	}
	.test-story-main .title {
		text-align: left;
	}
	.test-story-main h3 {
		text-align: center;
		page-break-inside: avoid;
	}
	.test-story-main h2 {
		text-align: center;
	}
	.test-story-main h1 {
		text-align: center;
	}
	.test-story-main .pgBrk {
		padding-top: 15px;
	}
	.test-story-main .er7Msg {
		width: 100%;
	}
	.test-story-main .embSpace {
		padding-left: 15px;
	}
	.test-story-main .accordion-heading {
		font-weight: bold;
		font-size: 90%;
	}
	.test-story-main .accordion-heading i.fa:after {
		content: "\00a0 ";
	}
	.test-story-main panel {
		margin: 10px 5px 5px 5px;
	}
}

@media print {
	.test-story-main legend {
		text-align: center;
		font-size: 110%;
		font-weight: bold;
	}
	.test-story-main .nav-tabs {
		font-weight: bold;
	}
	.test-story-main .obxGrpSpl {
		background: #B8B8B8;
	}
	.test-story-main maskByMediaType {
		display: table;
	}
	.test-story-main table tbody tr th {
		font-size: 90%
	}
	.test-story-main table tbody tr td {
		font-size: 90%;
	}
	.test-story-main table tbody tr th {
		text-align: left;
		background: #C6DEFF;
	}
	.test-story-main table thead tr th {
		text-align: center;
		background: #4682B4;
	}
	.test-story-main fieldset {
		text-align: center;
		page-break-inside: avoid;
	}
	.test-story-main table {
		width: 98%;
		border: 1px groove;
		table-layout: fixed;
		margin: 0 auto;
		page-break-inside: avoid;
		border-collapse: collapse;
	}
	.test-story-main table tr {
		border: 2px groove;
	}
	.test-story-main table th {
		border: 2px groove;
	}
	.test-story-main table td {
		border: 1px groove;
	}
	.test-story-main table thead {
		border: 1px groove;
		background: #446BEC;
		text-align: left;
	}
	.test-story-main .separator {
		background: rgb(240, 240, 255);
		text-align: left;
	}
	.test-story-main table tbody tr td {
		text-align: left;
	}
	.test-story-main .noData {
		background: #B8B8B8;
	}
	.test-story-main .childField {
		background: #B8B8B8;
	}
	.test-story-main .tds_title {
		text-align: left;
		margin-bottom: 1%
	}
	.test-story-main h3 {
		text-align: center;
	}
	.test-story-main h2 {
		text-align: center;
	}
	.test-story-main h1 {
		text-align: center;
	}
	.test-story-main .tds_pgBrk {
		page-break-after: always;
	}
	.test-story-main #er7Message table {
		border: 0px;
		width: 80%
	}
	.test-story-main #er7Message td {
		background: #B8B8B8;
		font-size: 65%;
		margin-top: 6.0pt;
		border: 0px;
		text-wrap: preserve-breaks;
		white-space: pre;
	}
	.test-story-main .er7Msg {
		width: 100%;
		font-size: 80%;
	}
	.test-story-main .er7MsgNote {
		width: 100%;
		font-style: italic;
		font-size: 80%;
	}
	.test-story-main .embSpace {
		padding-left: 15px;
	}
	.test-story-main .embSubSpace {
		padding-left: 25px;
	}
	.test-story-main .accordion-heading {
		font-weight: bold;
		font-size: 90%;
	}
	.test-story-main .accordion-heading i.fa:after {
		content: "\00a0 ";
	}
	.test-story-main panel {
		margin: 10px 5px 5px 5px;
	}
}
</style>
</head>
<body>
	<!-- generated by TestStory_v1.xslt Version:1.0   Profile:TestStory-->
	<fieldset>
		<div class="test-story-main">
			<table><tr><th>Description</th></tr><tr><td><p>A vaccine administering practitioner at Oregon Family Medicine attempts to administer Hepatitis A vaccine to Selma Nadia McKay (DOB 02/05/2023) based on the order previously entered.<br><br></p><p><br></p></td></tr></table><br/><table><tr><th>Pre-condition</th></tr><tr><td><p>&middot; &nbsp; &nbsp; &nbsp;Selma Nadia McKay (DOB 02/05/2023) is registered in the SUT<br>&middot; &nbsp; &nbsp; &nbsp;SUT includes an adverse event recorded for Selma Nadia McKay (DOB 02/05/2023) with causative agent = Hep A ped/adol, 2 dose (83) and reaction = anaphylaxis (SNOMED-CT 39579001) onset 12/22/2023<br>&middot; &nbsp; &nbsp; &nbsp;Hep A vaccine order exists (i.e., has been placed)<br>&middot; &nbsp; &nbsp; &nbsp;SUT provides a list of available vaccine product to fulfill the order for Hepatitis A vaccine<br><br>Daniela Jennifer Wyatt is the administering practitioner.</p></td></tr></table><br/><table><tr><th>Post-Condition</th></tr><tr><td><p>Selection for any Hep A ped/adol product provides evidence of the prior reaction and the administration is avoided.</p><p>Go to step 4.1.1</p></td></tr></table><br/><table><tr><th>Test Objectives</th></tr><tr><td><p>To test the capability that the SUT informs the individual administering a vaccine that the patient had an adverse reaction this vaccine in the past. The method and timing of notification can be specified to meet local clinical workflow. This requirement is a &ldquo;failsafe&rdquo; mechanism in case the practitioner orders a vaccine dose that may be unsafe for the patient.</p><p><br></p></td></tr></table><br/><table><tr><th>Evaluation Criteria</th></tr><tr><td><p>The practitioner prepares to administer the Hepatitis A vaccine, and system informs the practitioner that the patient had an adverse reaction in the past. Successful performance requires:</p><p>The administration workflow includes clear evidence of a previous adverse reaction to Hepatitis A vaccine in at least one of the following ways (only 1 method is required):</p><p>* The SUT provides a &quot;task&quot; for the administering practitioner. The &quot;task&quot; indicates an order exists to administer Hepatitis A vaccine to this patient and includes indication about a previous adverse reaction within the task message. The practitioner user then selects the option to choose a product to administer.</p><p>* The order, when opened, shows evidence that a warning about a previous adverse reaction has been overridden</p><p>* The available vaccine products display evidence of a concern regarding each of the Hepatitis A vaccine products</p><p>* Selection of a specific Hepatitis A vaccine to administer includes indication of a concern to move forward with the administration</p><p><br></p></td></tr></table><br/>
		</div>
	</fieldset>
</body>
</html>